logo

Stock Screener

Forex Screener

Crypto Screener

ADUS

Addus HomeCare Corporation (ADUS)

$

110.27

-2.11 (-1.91%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

5.2776

Market cap

Market cap

2 Billion

Price to sales ratio

Price to sales ratio

1.5931

Debt to equity

Debt to equity

0.2175

Current ratio

Current ratio

1.7376

Income quality

Income quality

2.5302

Average inventory

Average inventory

0

ROE

ROE

0.0843



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Addus HomeCare Corporation, along with its subsidiaries, delivers vital personal care services to elderly individuals, those with chronic illnesses, and disabled persons, as well as individuals at risk of hospitalization or institutionalization across the United States. The company operates through three primary segments: Personal Care, Hospice, and Home Health. The Personal Care segment is dedicated to providing non-medical support with daily activities, including bathing, grooming, oral care, feeding, dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. In the Hospice segment, Addus offers palliative nursing care, social work, spiritual counseling, homemaker assistance, and bereavement counseling for terminally ill patients and their families. Meanwhile, the Home Health segment caters to individuals requiring skilled nursing and therapies such as physical, occupational, and speech therapy during illness or post-hospitalization. The company's payor clients encompass federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. As of December 31, 2021, Addus served consumers through 206 offices across 22 states. The gross profit stands at $375,021,000.00 highlighting the company's profitability from core operations. The company incurred an income tax expense of $25,755,000.00 indicating its tax obligations. The income before tax ratio is 0.09 reflecting the pre-tax margin. The company recorded a net income of $73,598,000.00 reflecting its profitability. Additionally, the weighted average number of shares outstanding is 17,006,000.00 highlighting the company's shareholder base. The stock is reasonably priced at $110.27 appealing to a broad range of investors. Despite having a low average trading volume of 157,825.00 indicating lower market activity, Addus HomeCare maintains a mid-range market capitalization of $2,029,761,944.00 positioning it as a steady performer. The company is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. It belongs to the Healthcare sector, driving innovation and growth. This blend of stable operations and strategic market positioning makes Addus HomeCare a notable presence in its field, attracting interest from investors while fulfilling a crucial role in providing care to those in need.

What is Addus HomeCare Corporation (ADUS)'s current stock price?

The current stock price of Addus HomeCare Corporation (ADUS) is $110.27 as of 2025-09-12. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Addus HomeCare Corporation (ADUS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Addus HomeCare Corporation stock to fluctuate between $88.96 (low) and $136.72 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-09-12, Addus HomeCare Corporation's market cap is $2,029,761,944, based on 18,407,200 outstanding shares.

Compared to Eli Lilly & Co., Addus HomeCare Corporation has a Lower Market-Cap, indicating a difference in performance.

To buy Addus HomeCare Corporation (ADUS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ADUS. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $1,154,599,000 | EPS: $4.33 | Growth: 10.74%.

Visit https://addus.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $136.72 (2025-01-22) | All-time low: $68.57 (2022-02-24).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

ADUS

seekingalpha.com

Addus HomeCare: Decent Print, Weak Economics, Stay On Hold

Q2 revenue was $349.4m, up 21.8% YoY, with adjusted EBITDA of $43.9m and operating cash flow of $22.5m. The business continues to acquire growth and has committed $1.20 in M&A per $1 of new sales over the last 3 years. Returns on capital remain low at ~8–9%, with fair value estimated at $80–$90/share.

ADUS

fool.com

Addus HomeCare (ADUS) Q2 Revenue Up 22%

Addus HomeCare (ADUS) Q2 Revenue Up 22%

ADUS

zacks.com

Addus HomeCare (ADUS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ADUS

zacks.com

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.35 per share a year ago.

ADUS

zacks.com

ADUS vs. USPH: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?

ADUS

seekingalpha.com

Addus HomeCare Corporation (ADUS) Q1 2025 Earnings Call Transcript

Addus HomeCare Corporation (NASDAQ:ADUS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Tao Qiu - Macquarie Jared Haase - William Blair Matthew Gillmor - KeyBanc Meghan Holtz - Jefferies Constantine Davides - Citizens Bank Ryan Langston - TD Cowen John Ransom - Raymond James Operator Good day, and welcome to the Addus HomeCare First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.

ADUS

zacks.com

Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ADUS

zacks.com

ADUS or USPH: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?

ADUS

zacks.com

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ADUS

zacks.com

Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains?

Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener